Agilent Technologies Triple Quadrupole ICP-MS Selected for R&D 100 Award
News Jul 15, 2013
Agilent Technologies Inc. announce that the 8800 Triple Quadrupole ICP-MS has been named an R&D 100 Award winner.
“The Agilent 8800 Triple Quadrupole ICP-MS is a groundbreaking innovation that redefines the possibilities of ultra-trace elemental analysis,” said Philip Binns, Agilent vice president for spectroscopy products. “The 8800 ICP-QQQ has enjoyed strong adoption in its first year and has defined a new segment in elemental analysis. We are honored that our spectroscopy division has won this award for two consecutive years.”
Unlike existing instruments, the Agilent 8800 is the only ICP-MS system with a tandem mass spectrometer, or MS/MS, configuration. Using a high-performance quadrupole before and after the collision/reaction cell, the 8800 precisely controls the ions in the instrument, allowing the user to resolve the most difficult interferences and obtain the highest sensitivity results of any ICP-MS.
The Agilent 8800 enables scientists and chemists to solve challenging analytical problems that have proven difficult for conventional ICP-MS systems in traditional markets such as semiconductors, environmental and food. Additionally, the 8800 offers new research capabilities providing scientists new application possibilities in fields such as life sciences.
The R&D 100 Awards have long been a benchmark of excellence for industry sectors as diverse as telecommunications, high-energy physics, software, manufacturing and biotechnology. Winners are selected by an independent judging panel and the editors of R&D Magazine.
In 2012, the Agilent 4100 Microwave Plasma-Atomic Emission Spectrometer (MP-AES) won an R&D 100 Award.
First Observation of Optical Light From Shock Breakout in a Supernova ExplosionNews
Thanks to lucky snapshots taken by an amateur astronomer in Argentina, scientists have obtained their first view of the initial burst of light from the explosion of a massive star.READ MORE
Bacteria Produce More Substances Than Genetics PredictedNews
Tandem mass spectrometry has revealed that Streptomyces chartreusis, an antibiotic-producing bacterium, releases more metabolites into the surrounding medium than scientists assumed based on the analysis of the genome. They might include molecules that are of interest as potential pharmaceutical agents.READ MORE